Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study-Reference-Cited by-同舟云学术

Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study

Published:2016-08-26 Issue:2 Volume:42 Page:562-571
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Wijtenburg S Andrea,Wright Susan N,Korenic Stephanie A,Gaston Frank E,Ndubuizu Nkemdilim,Chiappelli Joshua,McMahon Robert P,Chen Hongji,Savransky Anya,Du Xiaoming,Wang Danny J J,Kochunov Peter,Hong L Elliot,Rowland Laura M

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2016172.pdf

Reference57 articles.

1. Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L et al (2014). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73: 102–116.

2. Aoyama N, Theberge J, Drost DJ, Manchanda R, Northcott S, Neufeld RW et al (2011). Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia. Br J Psychiatry 198: 448–456.

3. Busija DW, Bari F, Domoki F, Louis T (2007). Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex. Brain Res Rev 56: 89–100.

4. Bustillo J, Barrow R, Paz R, Tang J, Seraji-Bozorgzad N, Moore GJ et al (2006). Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology 31: 751–756.

5. Bustillo JR, Chen H, Jones T, Lemke N, Abbott C, Qualls C et al (2014). Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study at 3 T. JAMA Psychiatry 71: 265–272.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders — A systematic review and Meta-Analysis;Brain, Behavior, and Immunity;2024-01

2. Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2023-03

3. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status;NeuroImage: Clinical;2023

4. Research Applications of Positron Emission Tomography/Magnetic Resonance (PET/MR) Imaging in Schizophrenia;PET/MR: Functional and Molecular Imaging of Neurological Diseases and Neurosciences;2023

5. The Relationship Between Resting Cerebral Blood Flow, Neurometabolites, Cardio-Respiratory Fitness and Aging-Related Cognitive Decline;Frontiers in Psychiatry;2022-06-09